Concentrix Corporation
NASDAQ:CNXC
40.72 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Revenue
| 7,114.706 | 6,324.473 | 5,587.015 | 4,719.534 | 4,707.912 | 2,463.151 | 1,990.18 |
Cost of Revenue
| 4,536.771 | 4,067.21 | 3,617.527 | 3,058.009 | 2,959.464 | 1,525.599 | 1,241.026 |
Gross Profit
| 2,577.935 | 2,257.263 | 1,969.488 | 1,661.525 | 1,748.448 | 937.552 | 749.154 |
Gross Profit Ratio
| 0.362 | 0.357 | 0.353 | 0.352 | 0.371 | 0.381 | 0.376 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 1,916.608 | 1,617.071 | 1,397.091 | 1,352.764 | 1,454.116 | 792.791 | 634.531 |
Other Expenses
| -52.095 | 34.887 | 6.345 | 7.447 | 2.28 | 4.386 | -2.326 |
Operating Expenses
| 1,916.608 | 1,617.071 | 1,397.091 | 1,352.764 | 1,454.116 | 792.791 | 634.531 |
Operating Income
| 661.327 | 365.542 | 301.567 | 39.642 | 294.332 | 144.761 | 114.623 |
Operating Income Ratio
| 0.093 | 0.058 | 0.054 | 0.008 | 0.063 | 0.059 | 0.058 |
Total Other Income Expenses Net
| -52.095 | 239.461 | 254.129 | 228.253 | -89.916 | -33.853 | -2.326 |
Income Before Tax
| 408.228 | 605.003 | 555.696 | 267.895 | 204.416 | 110.908 | 88.277 |
Income Before Tax Ratio
| 0.057 | 0.096 | 0.099 | 0.057 | 0.043 | 0.045 | 0.044 |
Income Tax Expense
| 94.386 | 169.363 | 150.119 | 103.084 | 87.252 | 62.637 | 16.027 |
Net Income
| 313.842 | 435.049 | 405.577 | 164.811 | 117.164 | 48.271 | 72.25 |
Net Income Ratio
| 0.044 | 0.069 | 0.073 | 0.035 | 0.025 | 0.02 | 0.036 |
EPS
| 5.72 | 8.34 | 7.78 | 3.19 | 2.27 | 0.94 | 1.4 |
EPS Diluted
| 5.7 | 8.28 | 7.7 | 3.19 | 2.27 | 0.93 | 1.4 |
EBITDA
| 997.527 | 675.079 | 578.742 | 316.208 | 602.392 | 303.745 | 242.165 |
EBITDA Ratio
| 0.14 | 0.107 | 0.104 | 0.067 | 0.128 | 0.123 | 0.122 |